BAY1101042

DRUG2 trials

Sponsors

Bayer

Conditions

Healthy VolunteerRenal Impairment

Phase 1

Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single Oral 10 mg BAY1101042 Tablet Dose in Men and Woman With Renal Impairment and in Healthy Subjects

CompletedNCT03235076

BayerRenal Impairment

Start: 2017-08-15End: 2019-03-13Updated: 2023-06-05

Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single and Multiple Oral BAY1101042 Tablet Doses in Healthy Male Subjects

CompletedNCT03252002

BayerHealthy Volunteer

Start: 2017-08-16End: 2019-07-24Updated: 2019-08-19